S027 Updates in Hair Disorders
DESCRIPTION
A wide spectrum of scalp disorders will be covered including alopecia areata, androgenetic hair loss, acute and chronic telogen effluvium, cicatricial alopecia, including lichen planopilaris and frontal fibrosing alopecia. Alopecias in cancer patients and survivors will be discussed. The efficacy of the latest treatments such as JAK inhibitors, topical and intralesional anti-androgens will be evaluated. Trichoscopy and scalp pathology in distinguishing scalp disorders will be emphasized. An update on surgical techniques in hair transplantation will be presented. Ethnic hair disorders such as central centrifugal cicatricial alopecia in terms of recognition and treatment will be covered. Relaxers will be discussed.
LEARNING OBJECTIVES
Diagnose and manage cicatricial alopecias, alopecia areata, and androgenetic hair loss.
Distinguish scalp disorders by trichoscopy and scalp pathology.
Recognize ethnic hair disorders and issues and how to treat them
SCHEDULE
9:00 AM
LPP and FAPD Update
Jerry Shapiro, MD, FAAD
9:15 AM
JAK Inhibitors in Alopecia Areata, Clinical Pearls and Difficult Cases
Brett King, MD, PhD, FAAD
9:30 AM
GLP-1 Agonists and Hair Loss
Maryanne Makredes Senna, MD, FAAD
9:45 AM
Drug Safety During Breastfeeding
David Saceda-Corralo, MD, PhD
10:00 AM
How to Manage Difficult Cases of Androgenetic Alopecia
Daniel Melo, MD, MS, PhD, IFAAD
10:15 AM
Central Centrifugal Cicatricial Alopecia Updates
Crystal Aguh, MD, FAAD
10:30 AM
Trichoscopy as a Diagnostic Tool
Rodrigo Pirmez, MD
10:45 AM
Hair Loss in Cancer Patients and Survivors
11:00 AM
Rethinking Oral Minoxidil
Kristen Irene Lo Sicco, MD, FAAD
11:15 AM
Female Pattern Hair Loss Diagnosis and Management
Elise A. Olsen, MD, FAAD
11:30 AM
Folliculitis Decalvans Update
Lidia Rudnicka, MD, PhD, IFAAD
11:45 AM
Hair Transplant Update
Wenyu Wu, MD
DIRECTOR
Jerry Shapiro, MD, FAAD
Professor, Ronald O. Perelman Department of Dermatology, New York University, NY
SPEAKERS
Crystal Aguh, MD, FAAD
Johns Hopkins School of Medicine
Brett King, MD, PhD, FAAD
Kristen Irene Lo Sicco, MD, FAAD
Maryanne Makredes Senna, MD, FAAD
Daniel Melo, MD, MS, PhD, IFAAD
AIT - Advanced Institute of Trichology
Elise A. Olsen, MD, FAAD
Duke University
Rodrigo Pirmez, MD
Lidia Rudnicka, MD, PhD, IFAAD
David Saceda-Corralo, MD, PhD
Ramón y Cajal University Hospital, Madrid, Spain
Wenyu Wu, MD
DISCLOSURES
Crystal Aguh, MD, FAAD
CP Skin Health – Advisory Board(Honoraria); Eli Lilly and Company – Consultant(Fees); Johnson & Johnson – Other(Residency/Fellowship Program Funding); Pfizer Inc. – Consultant(Fees); Procter & Gamble Company – Consultant (1099 relationship)(Fees); UpToDate, Inc – Other(Fees); Veradermics – Advisory Board(Fees);
Brett King, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Almirall – Consultant (1099 relationship)(Fees); Amgen – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Aquestive Therapeutics – Consultant (1099 relationship)(Fees); BiologicsMD, Inc. – Consultant(Stock Options); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Galderma – Advisory Board(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Imagene Bio – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees); Leo Pharma – Advisory Board(Honoraria); Nektar Therapeutics – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Q32 Bio Inc. – Consultant (1099 relationship)(Fees); Regeneron – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Sanofi Genzyme – Speaker(Honoraria); Soterios Pharma – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant(Fees), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); TWi Biotechnology, Inc. – Consultant(Fees);
Kristen Irene Lo Sicco, MD, FAAD
AQUIS – Consultant (1099 relationship)(Fees); Eli Lilly – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees), Investigator(Grants/Research Funding); Priovant Therapeutics – Consultant (1099 relationship)(Fees); RegenLab – Investigator(Grants/Research Funding); Veradermics – Consultant (1099 relationship)(Fees);
Maryanne Makredes Senna, MD, FAAD
AbbVie – Advisory Board(Fees); American Hair Research Society – Board of Directors(No Compensation Received); Cicatricial Alopecia Research Foundation – Board of Directors(No Compensation Received); CoreEvitas, LLC – Advisory Board(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Fees); GLife – Advisory Board(Stock Options); Inmagene – Investigator(Grants/Research Funding); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Kintor Pharmaceutical Limited – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Fees), Speaker(Fees); Priovant Therapeutics – Advisory Board(Fees), Investigator(Grants/Research Funding); Q32 Bio Inc. – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Veradermics – Advisory Board(Fees), Advisory Board(Stock);
Daniel Melo, MD, MS, PhD, IFAAD
No financial relationships exist with ineligible companies.
Elise A. Olsen, MD, FAAD
Absci – Advisory Board(Honoraria); Aranda Pharm Ltd – Consultant (1099 relationship)(Honoraria); Canfield Scientific, Inc. – Consultant(Honoraria); Cosmos S.I. – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Taisho Pharmaceuticals Co., Ltd. – Consultant (1099 relationship)(Honoraria); United States Cutaneous Lymphoma Consortium – Other(Grants/Research Funding); UpToDate, Inc – Other(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Rodrigo Pirmez, MD
Ache Laboratório Farmaceuticso S.A. – Consultant(Fees); Darrow – Consultant(Fees); FotoFinder Systems GmbH – Speaker(Fees); GlaxoSmithKline Immunology – Speaker(Fees); Pfizer Inc. – Consultant(Fees);
Lidia Rudnicka, MD, PhD, IFAAD
No financial relationships exist with ineligible companies.
David Saceda-Corralo, MD, PhD
Cantabria Labs – Advisory Board(Fees), Investigator(No Compensation Received); Concert Pharmaceuticals – Investigator(No Compensation Received); Eli Lilly and Company – Advisory Board(Fees), Speaker(Honoraria); ISDIN – Advisory Board(Fees), Speaker(Fees); L'Oreal – Advisory Board(Fees), Speaker(Fees); Olistic Science – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees), Investigator(Residency/Fellowship Program Funding), Speaker(Fees);
Jerry Shapiro, MD, FAAD
30 Madison – Consultant (1099 relationship)(Stock Options); AbbVie – Consultant (1099 relationship)(Honoraria); Almirall – Consultant (1099 relationship)(Honoraria); DS Laboratories – Consultant (1099 relationship)(Honoraria); Eirion Therapeutics – Consultant (1099 relationship)(Stock Options); Eli Lilly – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Veradermics – Consultant (1099 relationship)(Fees), Stockholder Public Company(No Compensation Received);
Wenyu Wu, MD
No financial relationships exist with ineligible companies.